Chugai Pharmaceutical Co. Ltd.

11/16/2021 | Press release | Distributed by Public on 11/16/2021 00:06

Chugai Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic Profile to Identify TMB-High Tumors